{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:04:10Z","timestamp":1793714650247,"version":"4.6.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Fundaci\u00f3n Salud 2000 (ES)-Fundaci\u00f3n SEOM"},{"name":"Roche Farma S.A."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s10549-016-3792-1","type":"journal-article","created":{"date-parts":[[2016,4,15]],"date-time":"2016-04-15T03:19:32Z","timestamp":1460690372000},"page":"507-515","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial"],"prefix":"10.1007","volume":"156","author":[{"given":"Milagros","family":"Gonz\u00e1lez-Rivera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"L\u00f3pez-Tarruella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Jerez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"del Monte-Mill\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Massarrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Ramos-Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Oca\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Picornell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia Santill\u00e1n","family":"Garz\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"P\u00e9rez-Carbornero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"Garc\u00eda-Saenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"M\u00e1rquez-Rodas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,15]]},"reference":[{"issue":"15","key":"3792_CR1","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","volume":"13","author":"R Dent","year":"2007","unstructured":"Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA et al (2007) Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 13(15):4429\u20134434","journal-title":"Clin Cancer Res"},{"issue":"20","key":"3792_CR2","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1056\/NEJMra1001389","volume":"363","author":"WD Foulkes","year":"2010","unstructured":"Foulkes WD, Smith IE, Reis-Filho JS (2010) Triple-negative breast cancer. N Engl J Med 363(20):1938\u20131948","journal-title":"N Engl J Med"},{"issue":"21","key":"3792_CR3","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","volume":"295","author":"LA Carey","year":"2006","unstructured":"Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K et al (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA Am Med Assoc 295(21):2492\u20132502","journal-title":"JAMA Am Med Assoc"},{"issue":"19","key":"3792_CR4","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/jnci\/djg050","volume":"95","author":"WD Foulkes","year":"2003","unstructured":"Foulkes WD, Stefansson IM, Chappuis PO, B\u00e9gin LR, Goffin JR, Wong N et al (2003) Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst 95(19):1482\u20131485","journal-title":"J Natl Cancer Inst"},{"issue":"14","key":"3792_CR5","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1073\/pnas.0932692100","volume":"100","author":"T Sorlie","year":"2003","unstructured":"Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A et al (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100(14):8418\u20138423","journal-title":"Proc Natl Acad Sci USA"},{"key":"3792_CR6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/path.4205","volume":"230","author":"WD Foulkes","year":"2013","unstructured":"Foulkes WD, Shuen AY (2013) In Brief: BRCA1 and BRCA2. J Pathol 230:347\u2013349","journal-title":"J Pathol"},{"issue":"5","key":"3792_CR7","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PDP, Narod S, Risch HA, Eyfjord JE, Hopper JL et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117\u20131130","journal-title":"Am J Hum Genet"},{"issue":"11","key":"3792_CR8","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","volume":"25","author":"S Chen","year":"2007","unstructured":"Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25(11):1329\u20131333","journal-title":"J Clin Oncol"},{"key":"3792_CR9","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa1400382","volume":"371","author":"AC Antoniou","year":"2014","unstructured":"Antoniou AC, Casadei S, Heikkinen T, Barrowdale D, Pylk\u00e4s K, Roberts J et al (2014) Breast-cancer risk in families with mutations in PALB2. N Engl J Med 371:497\u2013506","journal-title":"N Engl J Med"},{"issue":"11","key":"3792_CR10","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/gim.2014.40","volume":"16","author":"H Laduca","year":"2014","unstructured":"Laduca H, Stuenkel AJ, Dolinsky JS, Keiles S, Tandy S, Pesaran T et al (2014) Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients. Genet Med 16(11):830\u2013837","journal-title":"Genet Med"},{"key":"3792_CR11","unstructured":"National Comprehensive Cancer Network (NCCN) 2015 The NCCN clinical practice guidelines in oncology TM 2010. Genetic\/familial high risk assessment: breast and ovarian v2.2015. www.nccn.com"},{"issue":"3","key":"3792_CR12","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s10549-014-2980-0","volume":"145","author":"P Sharma","year":"2014","unstructured":"Sharma P, Klemp JR, Kimler BF, Mahnken JD, Geier LJ, Khan QJ et al (2014) Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and\/or ovarian cancer syndrome testing. Breast Cancer Res Treat 145(3):707\u2013714","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"3792_CR13","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.6004\/jnccn.2014.0127","volume":"12","author":"MB Daly","year":"2014","unstructured":"Daly MB, Pilarski R, Axilbund JE, Buys SS, Crawford B, Friedman S et al (2014) Genetic\/familial high-risk assessment: breast and ovarian, version 1.2014. J Natl Compr Cancer Netw 12(9):1326\u20131338","journal-title":"J Natl Compr Cancer Netw"},{"key":"3792_CR14","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1007\/s12094-015-1435-3","volume":"17","author":"G Llort","year":"2015","unstructured":"Llort G, Chirivella I, Morales R, Serrano R, Sanchez AB, Teul\u00e9 A et al (2015) SEOM clinical guidelines in hereditary breast and ovarian cancer. Clin Transl Oncol 17:956\u2013961","journal-title":"Clin Transl Oncol"},{"issue":"6","key":"3792_CR15","first-page":"1","volume":"2","author":"P Domagala","year":"2015","unstructured":"Domagala P, Jakubowska A, Jaworska-bieniek K, Kaczmarek K, Durda K, Kurlapska A et al (2015) Prevalence of germline mutations in genes engaged in DNA damage repair by homologous recombination in patients with triple-negative and hereditary non- triple-negative breast cancers. PLoS One 2(6):1\u201314","journal-title":"PLoS One"},{"issue":"Supplement 5","key":"3792_CR16","doi-asserted-by":"crossref","first-page":"v8","DOI":"10.1093\/annonc\/mdv298","volume":"26","author":"E Senkus","year":"2015","unstructured":"Senkus E, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rutgers E et al (2015) Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 26(Supplement 5):v8\u2013v30","journal-title":"Ann Oncol"},{"key":"3792_CR17","unstructured":"NCT 01560663. Predictors of response to neoadjuvant docetaxel-carboplatin chemotherapy for patients with stage II and III triple negative breast cancer. https:\/\/clinicaltrials.gov\/ct2\/results?term=NCT+01560663&Search=Search"},{"issue":"31","key":"3792_CR18","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","volume":"31","author":"AC Wolff","year":"2013","unstructured":"Wolff AC, Hammond MEH, Hicks DG, Dowsett M, McShane LM, Allison KH et al (2013) Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American society of clinical oncology\/College of American pathologists clinical practice guideline update. J Clin Oncol 31(31):3997\u20134013","journal-title":"J Clin Oncol"},{"key":"3792_CR19","unstructured":"Meindl A, Ditsch N, Kast K, Rhiem K, Schmutzler RK (2011) Hereditary breast and ovarian cancer: new genes, new treatments, new concepts. Dtsch \u00c4rzteblatt Int. Deutscher Arzte-Verlag GmbH 108(19):323\u201330"},{"issue":"17","key":"3792_CR20","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/bioinformatics\/btp373","volume":"25","author":"DC Koboldt","year":"2009","unstructured":"Koboldt DC, Chen K, Wylie T, Larson DE, McLellan MD, Mardis ER et al (2009) VarScan: variant detection in massively parallel sequencing of individual and pooled samples. Bioinformatics 25(17):2283\u20132285","journal-title":"Bioinformatics"},{"issue":"9","key":"3792_CR21","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A et al (2010) The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20(9):1297\u20131303","journal-title":"Genome Res"},{"key":"3792_CR22","doi-asserted-by":"crossref","first-page":"D84","DOI":"10.1093\/nar\/gkr991","volume":"40","author":"P Flicek","year":"2012","unstructured":"Flicek P, Amode MR, Barrell D, Beal K, Brent S, Carvalho-Silva D et al (2012) Ensembl 2012. Nucleic Acids Res 40:D84\u2013D90","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"3792_CR23","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","volume":"27","author":"JS Parker","year":"2009","unstructured":"Parker JS, Mullins M, Cheang MCU, Leung S, Voduc D, Vickery T et al (2009) Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol Off J Am Soc Clin Oncol 27(8):1160\u20131167","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"3792_CR24","unstructured":"R Core Team (2015). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https:\/\/www.R-project.org\/"},{"issue":"6797","key":"3792_CR25","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, S\u00f8rlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA et al (2000) Molecular portraits of human breast tumours. Nature 406(6797):747\u2013752","journal-title":"Nature"},{"issue":"1","key":"3792_CR26","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10549-012-2021-9","volume":"134","author":"F Fostira","year":"2012","unstructured":"Fostira F, Tsitlaidou M, Papadimitriou C, Pertesi M, Timotheadou E, Stavropoulou AV et al (2012) Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study. Breast Cancer Res Treat 134(1):353\u2013362","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"3792_CR27","first-page":"1234","volume":"106","author":"L Robertson","year":"2012","unstructured":"Robertson L, Hanson H, Seal S, Warren-Perry M, Hughes D, Howell I et al (2012) BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50\u00a0years. Br J Cancer Nat Publ Group 106(6):1234\u20131238","journal-title":"Br J Cancer Nat Publ Group"},{"issue":"4","key":"3792_CR28","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1200\/JCO.2014.57.1414","volume":"33","author":"FJ Couch","year":"2015","unstructured":"Couch FJ, Hart SN, Sharma P, Toland AE, Wang X, Miron P et al (2015) Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer. J Clin Oncol 33(4):304\u2013311","journal-title":"J Clin Oncol"},{"key":"3792_CR29","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1002\/cncr.26576","volume":"118","author":"AR Hartman","year":"2012","unstructured":"Hartman AR, Kaldate RR, Sailer LM, Painter L, Grier CE, Endsley RR et al (2012) Prevalence of BRCA mutations in an unselected population of triple-negative breast cancer. Cancer 118:2787\u20132795","journal-title":"Cancer"},{"issue":"1","key":"3792_CR30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10549-015-3293-7","volume":"150","author":"MW Wong-Brown","year":"2015","unstructured":"Wong-Brown MW, Meldrum CJ, Carpenter JE, Clarke CL, Narod SA, Jakubowska A et al (2015) Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer. Breast Cancer Res Treat 150(1):71\u201380","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"3792_CR31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10549-012-2348-2","volume":"137","author":"S Rummel","year":"2013","unstructured":"Rummel S, Varner E, Shriver CD, Ellsworth RE (2013) Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer. Breast Cancer Res Treat 137(1):119\u2013125","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"3792_CR32","first-page":"1082","volume":"17","author":"AM Gonzalez-angulo","year":"2012","unstructured":"Gonzalez-angulo AM, Timms KM, Liu S, Chen H, Jennifer K, Potter J et al (2012) NIH Public Access 17(5):1082\u20131089","journal-title":"NIH Public Access"},{"issue":"5","key":"3792_CR33","doi-asserted-by":"crossref","first-page":"e38361","DOI":"10.1371\/journal.pone.0038361","volume":"7","author":"P Meyer","year":"2012","unstructured":"Meyer P, Landgraf K, H\u00f6gel B, Eiermann W, Ataseven B (2012) BRCA2 mutations and triple-negative breast cancer. PLoS One Public Library of Science 7(5):e38361","journal-title":"PLoS One Public Library of Science"},{"issue":"11","key":"3792_CR34","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s00432-015-1986-2","volume":"141","author":"A Muendlein","year":"2015","unstructured":"Muendlein A, Rohde BH, Gasser K, Haid A, Rauch S, Kinz E et al (2015) Evaluation of BRCA1\/2 mutational status among German and Austrian women with triple-negative breast cancer. J Cancer Res Clin Oncol 141(11):2005\u20132012","journal-title":"J Cancer Res Clin Oncol"},{"key":"3792_CR35","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s12094-013-1070-9","volume":"16","author":"R Andr\u00e9s","year":"2014","unstructured":"Andr\u00e9s R, Pajares I, Balma\u00f1a J, Llort G, Cajal TR, Chirivella I et al (2014) Association of BRCA1 germline mutations in young onset triple-negative breast cancer (TNBC). Clin Transl Oncol 16:280\u2013284","journal-title":"Clin Transl Oncol"},{"key":"3792_CR36","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2407-9-86","volume":"9","author":"SR Young","year":"2009","unstructured":"Young SR, Pilarski RT, Donenberg T, Shapiro C, Hammond LS, Miller J et al (2009) The prevalence of BRCA1 mutations among young women with triple-negative breast cancer. BMC Cancer 9:86","journal-title":"BMC Cancer"},{"issue":"Suppl 6","key":"3792_CR37","doi-asserted-by":"crossref","first-page":"vi31","DOI":"10.1093\/annonc\/mdr373","volume":"22","author":"J Balma\u00f1a","year":"2011","unstructured":"Balma\u00f1a J, D\u00edez O, Rubio IT, Cardoso F (2011) BRCA in breast cancer: ESMO Clinical Practice Guidelines. Ann Oncol Off J Eur Soc Med Oncol\/ESMO 22(Suppl 6):vi31\u2013vi34","journal-title":"Ann Oncol Off J Eur Soc Med Oncol\/ESMO"},{"issue":"3","key":"3792_CR38","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/cge.12620","volume":"89","author":"S Brakeleer De","year":"2016","unstructured":"De Brakeleer S, De Gr\u00e8ve J, Desmedt C, Joris S, Sotiriou C, Piccart M et al (2016) Frequent incidence of BARD1-truncating mutations in germline DNA from triple-negative breast cancer patients. Clin Genet 89(3):336\u2013340","journal-title":"Clin Genet"},{"issue":"7","key":"3792_CR39","first-page":"2113","volume":"5","author":"M Ollier","year":"2015","unstructured":"Ollier M, Radosevic-Robin N, Kwiatkowski F, Ponelle F, Viala S, Privat M et al (2015) DNA repair genes implicated in triple negative familial non-BRCA1\/2 breast cancer predisposition. Am J Cancer Res. 5(7):2113\u20132126","journal-title":"Am J Cancer Res."},{"issue":"3","key":"3792_CR40","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/cge.12315","volume":"86","author":"JM Eggington","year":"2014","unstructured":"Eggington JM, Bowles KR, Moyes K, Manley S, Esterling L, Sizemore S et al (2014) A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes. Clin Genet 86(3):229\u2013237","journal-title":"Clin Genet"},{"issue":"4","key":"3792_CR41","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10689-014-9741-4","volume":"13","author":"CG Selkirk","year":"2014","unstructured":"Selkirk CG, Vogel KJ, Newlin AC, Weissman SM, Weiss SM, Wang C-H et al (2014) Cancer genetic testing panels for inherited cancer susceptibility: the clinical experience of a large adult genetics practice. Fam Cancer 13(4):527\u2013536","journal-title":"Fam Cancer"},{"issue":"12","key":"3792_CR42","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/GIM.0b013e318226fc15","volume":"13","author":"ML Murray","year":"2011","unstructured":"Murray ML, Cerrato F, Bennett RL, Jarvik GP (2011) Follow-up of carriers of BRCA1 and BRCA2 variants of unknown significance: variant reclassification and surgical decisions. Genet Med 13(12):998\u20131005","journal-title":"Genet Med"},{"issue":"12","key":"3792_CR43","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13073-014-0121-3","volume":"6","author":"JY Cheon","year":"2014","unstructured":"Cheon JY, Mozersky J, Cook-Deegan R (2014) Variants of uncertain significance in BRCA: a harbinger of ethical and policy issues to come? Genome Med. 6(12):121","journal-title":"Genome Med."},{"issue":"3","key":"3792_CR44","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1188\/15.ONF.316-318","volume":"42","author":"SM Mahon","year":"2015","unstructured":"Mahon SM (2015) Management of patients with a genetic variant of unknown significance. Oncol Nurs Forum 42(3):316\u2013318","journal-title":"Oncol Nurs Forum"},{"key":"3792_CR45","doi-asserted-by":"crossref","first-page":"5846","DOI":"10.1038\/sj.onc.1209876","volume":"25","author":"NC Turner","year":"2006","unstructured":"Turner NC, Reis-Filho JS (2006) Basal-like breast cancer and the BRCA1 phenotype. Oncogene 25:5846\u20135853","journal-title":"Oncogene"},{"issue":"2","key":"3792_CR46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1634\/theoncologist.2012-0397","volume":"18","author":"A Prat","year":"2013","unstructured":"Prat A, Adamo B, Cheang MCU, Anders CK, Carey LA, Perou CM (2013) Molecular characterization of basal-like and non-basal-like triple-negative breast cancer. Oncologist. 18(2):123\u2013133","journal-title":"Oncologist."},{"issue":"2","key":"3792_CR47","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10549-014-3167-4","volume":"148","author":"J Zugazagoitia","year":"2014","unstructured":"Zugazagoitia J, P\u00e9rez-Segura P, Manzano A, Blanco I, Vega A, Custodio A et al (2014) Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers. Breast Cancer Res Treat 148(2):415\u2013421","journal-title":"Breast Cancer Res Treat"},{"issue":"23","key":"3792_CR48","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1001\/jama.297.23.2587","volume":"297","author":"JN Weitzel","year":"2007","unstructured":"Weitzel JN, Lagos VI, Cullinane CA, Gambol PJ, Culver JO, Blazer KR et al (2007) Limited family structure and BRCA gene mutation status in single cases of breast cancer. JAMA 297(23):2587\u20132595","journal-title":"JAMA"}],"updated-by":[{"DOI":"10.1007\/s10549-017-4396-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T00:00:00Z","timestamp":1500336000000}}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3792-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-016-3792-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3792-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T18:33:00Z","timestamp":1600453980000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-016-3792-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["3792"],"URL":"https:\/\/doi.org\/10.1007\/s10549-016-3792-1","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s10549-017-4396-0","asserted-by":"object"}]},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}